William Pridgen, Director at Virios Therapeutics, Inc. (VIRI), bought 4,301 shares at $7.47 ($32K) on 2021-01-29, disclosed to the SEC on 2021-02-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.80 | 801 | $6K | 19.3% |
| 2 | $7.47 | 3,500 | $26K | 80.7% |
| Total | $7.53 avg | 4,301 | $32K | 100% |
| Filing → |
| VIRI | BUY | 2022-05-18 | $59K | — | Filing → |
| VIRI | BUY | 2022-03-30 | $3K | — | Filing → |
| VIRI | BUY | 2022-03-24 | $12K | — | Filing → |